Literature DB >> 29048460

Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality.

Sebastian Hilbert1, Cosima Jahnke1, Susanne Loebe1, Sabrina Oebel1, Alexander Weber1, Ricardo Spampinato2, Sergio Richter1, Michael Doering1, Andreas Bollmann1, Philipp Sommer1, Gerhard Hindricks1, Ingo Paetsch1.   

Abstract

Aims: To prospectively determine evaluability of routine cardiovascular magnetic resonance (CMR) diagnostic modules in a referral population of implanted rhythm device all-comers, and to establish a device-dependent CMR imaging strategy to achieve optimal image quality. Methods and results: One hundred and twenty-eight patients with cardiac implantable electronic devices [insertable cardiac monitoring system, n = 14; implantable loop-recorder, n = 21; pacemaker, n = 31; implantable cardioverter-defibrillator (ICD), n = 50; and cardiac resynchronization therapy defibrillator (CRT-D), n = 12] underwent clinically indicated CMR at 1.5 T. CMR protocols were tailored to the clinical indication and consisted of cine, perfusion, T1-/T2-weighted, late-gadolinium enhancement (LGE), 3D angiographic, and post-contrast cine spoiled gradient echo (SGE) scans. Image quality was determined using a 4-grade visual score per myocardial segment. Segmental evaluability was strongly influenced by device type and location with the highest proportion of non-diagnostic images encountered in the presence of ICD/CRT-D systems. Cine steady-state free-precession (SSFP) imaging was found to be mostly non-diagnostic in ICD/CRT-D patients, but a significant improvement of image quality was demonstrated when using SGE sequences with a further incremental improvement post-contrast resulting in an overall four-fold higher likelihood of achieving good image quality. LGE scans were found to be non-diagnostic in about one-third of left-ventricular segments of ICD/CRT-D patients but were artefact-free in > 94% for all other device types.
Conclusion: Device type and location constitute the main independent predictors of CMR image quality and thus, need to be considered during protocol adaptation. Most notably, post-contrast SGE cine imaging proved superior to conventionally used SSFP sequences. Thus, following the proposed device-dependent CMR imaging strategy, diagnostic image quality can be achieved in the majority of device patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29048460     DOI: 10.1093/ehjci/jex243

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  13 in total

Review 1.  [Cardiovascular magnetic resonance imaging in patients with cardiac devices : Useful tool or just artifacts?]

Authors:  Sebastian Hilbert; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-07-04

2.  Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.

Authors:  Aino-Maija Vuorinen; Lauri Lehmonen; Jarkko Karvonen; Miia Holmström; Sari Kivistö; Touko Kaasalainen
Journal:  Eur Radiol       Date:  2022-08-27       Impact factor: 7.034

3.  Managing Patients With Advanced Atrioventricular Block: The Essential Role of Cardiovascular Magnetic Resonance Imaging for Timely and Accurate Diagnosis.

Authors:  Lisa von Wald; Chetan Shenoy
Journal:  J Am Heart Assoc       Date:  2022-06-06       Impact factor: 6.106

4.  Impact of Wideband Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging on Device-Related Artifacts in Different Implantable Cardioverter-Defibrillator Types.

Authors:  Amita Singh; Wensu Chen; Hena N Patel; Nazia Alvi; Keigo Kawaji; Stephanie A Besser; Roderick Tung; Jiangang Zou; Roberto M Lang; Victor Mor-Avi; Amit R Patel
Journal:  J Magn Reson Imaging       Date:  2021-03-19       Impact factor: 4.813

Review 5.  [Benefits of cardiac magnetic resonance diagnostics in patients with heart rhythm disorders : From risk stratification to interventional procedures].

Authors:  S Oebel; C Jahnke; G Hindricks; I Paetsch
Journal:  Herz       Date:  2022-03-11       Impact factor: 1.443

6.  Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms.

Authors:  Frank Lindemann; Sabrina Oebel; Ingo Paetsch; Arash Arya; Nikolaos Dagres; Sergio Richter; Borislav Dinov; Sebastian Hilbert; Susanne Loebe; Clara Stegmann; Michael Doering; Andreas Bollmann; Gerhard Hindricks; Cosima Jahnke
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

7.  Safety and image quality of cardiovascular magnetic resonance imaging in patients with retained epicardial pacing wires after heart transplantation.

Authors:  Constantin Gatterer; Marie-Elisabeth Stelzmüller; Andreas Kammerlander; Andreas Zuckermann; Martin Krššák; Christian Loewe; Dietrich Beitzke
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-15       Impact factor: 5.364

8.  Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators.

Authors:  Anna Giulia Pavon; Alessandra Pia Porretta; Dimitri Arangalage; Giulia Domenichini; Tobias Rutz; Sarah Hugelshofer; Etienne Pruvot; Pierre Monney; Patrizio Pascale; Juerg Schwitter
Journal:  J Cardiovasc Magn Reson       Date:  2022-01-13       Impact factor: 5.364

9.  Evaluation of image quality of wideband single-shot late gadolinium-enhancement MRI in patients with a cardiac implantable electronic device.

Authors:  Sarah M Schwartz; Ashitha Pathrose; Ali M Serhal; Ann B Ragin; Jessica Charron; Bradley P Knight; Rod S Passman; Ryan J Avery; Daniel Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2020-11-13

Review 10.  Magnetic resonance imaging guidance for the optimization of ventricular tachycardia ablation.

Authors:  Rahul K Mukherjee; John Whitaker; Steven E Williams; Reza Razavi; Mark D O'Neill
Journal:  Europace       Date:  2018-11-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.